Tempest closes CAR T asset acquisition from Erigen; Erigen owns 61.3% post-closing

Tempest Therapeutics, Inc.

Acquired ERI-2003, ERI-2206, ERI-3003, ERI-3206 CAR T therapies; issued 8.27M shares to Erigen.
Erigen owns 61.3% of outstanding shares (13.48M total); its members Angel and Lotus Capital to own ~35.9% and 25.5%.
Geoff Nichol resigned from Board; Michael Raab stepped down as Chair; Stephen Brady appointed Chair.
Stephen Brady resigned as CEO; Matt Angel appointed President, CEO and Class I director; $650k salary, 50% bonus, 269,621 option.
Issued 6.78M warrants at $18.48/exercise, expiring Feb 3 2031, to existing shareholders as a dividend.

item 1.01 item 2.01 item 3.02 item 5.01 item 5.02 item 9.01

Machine-readable event card

schema_version: secwatch.filing_event.v1
accession: 0001193125-26-041190
form_type: 8-K
ticker: TPST
cik: 0001544227
company_name: Tempest Therapeutics, Inc.
filed_at: 2026-02-06T23:59:59+00:00
discovered_at: 2026-05-14T18:02:35.389953+00:00
generated_at: 2026-05-16T04:05:13.295292+00:00
sec_items: ["1.01", "2.01", "3.02", "5.01", "5.02", "9.01"]
event_type: m_and_a
sentiment: neutral
materiality_score: 0.95
confidence: high
secwatch_canonical_url: https://secwatch.observer/filing/0001193125-26-041190
json_url: https://secwatch.observer/filing/0001193125-26-041190.json
markdown_url: https://secwatch.observer/filing/0001193125-26-041190.md
text_url: https://secwatch.observer/filing/0001193125-26-041190.txt
edgar_index_url: https://www.sec.gov/Archives/edgar/data/1544227/000119312526041190/0001193125-26-041190-index.htm
edgar_primary_document_url: https://www.sec.gov/Archives/edgar/data/1544227/000119312526041190/d159400d8k.htm
generated_by_model: deepseek-v4-flash:cloud@v2
review_status: machine_generated
human_reviewed: false
corrected: false
correction_note: null
correction_timestamp: null
superseded_by: null

JSON Markdown Plain text

Source: SEC EDGAR

accession 0001193125-26-041190

view filing index on sec.gov

view primary document

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.